Emma Cacciola
Overview
Explore the profile of Emma Cacciola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations
Giordano L, Cacciola R, Barone P, Vecchio V, Nasso M, Alvaro M, et al.
Diagnostics (Basel)
. 2024 Jun;
14(11).
PMID: 38893662
Multiple myeloma and monoclonal gammopathy of undetermined significance are plasma cell dyscrasias characterized by monoclonal proliferation of pathological plasma cells with uncontrolled production of immunoglobulins. Autoimmune pathologies are conditions in...
2.
Intagliata E, Vecchio R, Vizzini C, Villari L, Cacciola R, Cacciola E, et al.
J Surg Case Rep
. 2024 Feb;
2024(2):rjae073.
PMID: 38370604
Castleman disease is a rare and benign disorder, characterized by enlarged lymph nodes and angiofollicular lymphoid hyperplasia. We report a case of a 57-year-old male, who was admitted to our...
3.
Barbui T, Vannucchi A, De Stefano V, Carobbio A, Ghirardi A, Carioli G, et al.
NEJM Evid
. 2024 Feb;
2(6):EVIDoa2200335.
PMID: 38320126
BACKGROUND: Whether phlebotomy alone can adequately maintain target hematocrit in patients with low-risk polycythemia vera (PV) remains elusive. METHODS: In a phase 2 open-label randomized trial, we compared ropeginterferon alfa-2b...
4.
Barbui T, Carobbio A, De Stefano V, Alvarez-Larran A, Ghirardi A, Carioli G, et al.
Ann Hematol
. 2023 Dec;
103(2):437-442.
PMID: 38060001
In patients with low-risk polycythemia vera, exposure to low-dose Ropeginterferon alfa-2b (Ropeg) 100 µg every 2 weeks for 2 years was more effective than the standard treatment of therapeutic phlebotomy...
5.
Fulvio G, Baldini C, Mosca M, Di Paolo A, Bocci G, Palumbo G, et al.
Front Med (Lausanne)
. 2023 Nov;
10:1254868.
PMID: 37915324
In this article, we reviewed the possible mechanisms linking the clonal hematopoiesis of indeterminate potential (CHIP) to chronic myeloproliferative neoplasms (MPNs), autoimmune diseases (ADs), and cardiovascular diseases (CADs). CHIP is...
6.
Musso N, Romano A, Bonacci P, Scandura G, Pandino C, Camarda M, et al.
Int J Mol Sci
. 2022 Oct;
23(19).
PMID: 36233350
In multiple myeloma (MM), circulating tumor plasma cells (CTPCs) are an emerging prognostic factor, offering a promising and minimally invasive means for longitudinal patient monitoring. Recent advances highlight the complex...
7.
Impact of Anti-Endothelial Cell Antibodies (AECAs) in Patients with Polycythemia Vera and Thrombosis
Cacciola R, Gentilini Cacciola E, Vecchio V, Cacciola E
Diagnostics (Basel)
. 2022 May;
12(5).
PMID: 35626232
Polycythemia vera (PV) causes thrombosis. Erythrocytosis and cell adhesiveness are responsible for thrombosis. JAK2V617F causes inflammation and autoimmunity; however, whether or not autoimmunity or inflammation causes thrombosis has yet to...
8.
Stella S, Vitale S, Stagno F, Massimino M, Puma A, Tomarchio C, et al.
Diagnostics (Basel)
. 2022 May;
12(5).
PMID: 35626209
Background: Detection of transcript level via real-time quantitative-polymerase-chain reaction (Q-PCR) is a clinical routine for disease monitoring, assessing Tyrosine Kinase Inhibitor therapy efficacy and predicting long-term response in chronic myeloid...
9.
Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
Cacciola R, Gentilini Cacciola E, Vecchio V, Cacciola E
J Thromb Thrombolysis
. 2021 Oct;
53(2):282-290.
PMID: 34687400
Introduction: Coronavirus 2 (CoV-2) infection or coronavirus disease 2019 (COVID-19) is frequently associated with microvascular thrombosis.The microthrombosis in COVID-19 is the result of the interplay between inflammation and endotheliopathy. Elevated...
10.
Vecchio R, Cacciola E, Intagliata E
J Indian Assoc Pediatr Surg
. 2021 Jan;
25(6):416-417.
PMID: 33487952
No abstract available.